CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Aragon Pharmaceuticals is a small-molecule drug discovery company focused on developing medicines for the treatment of hormonally-driven cancers. These cancers eventually become resistant to existing 1st generation antihormonal therapies, and follow-...Show all
Company (Acquired)
Phone: 858-334-4830
12780 El Camino Real
Suite 301
San Diego, 92130
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Aragon Pharmaceuticals | $122M | Aug 19, 2013 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | May 20, 2019 | Oct 13, 2020 | Patent |
| Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | May 17, 2019 | Oct 13, 2020 | Patent |
| Crystalline forms of an androgen receptor modulator | Dec 11, 2019 | Sep 08, 2020 | Patent |
| Processes for the preparation of a diarylthiohydantoin compound | May 31, 2019 | Jul 28, 2020 | Patent |
| Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer | Apr 30, 2018 | Jul 07, 2020 | Patent |
